The relation of bioavailability to the dissolution rate of experimentally produced digoxin tablets. 1974

B F Johnson, and H Greer, and J A McCrerie, and C Bye, and A S Fowle

UI MeSH Term Description Entries
D008297 Male Males
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

B F Johnson, and H Greer, and J A McCrerie, and C Bye, and A S Fowle
July 1975, Journal of pharmaceutical sciences,
B F Johnson, and H Greer, and J A McCrerie, and C Bye, and A S Fowle
December 1973, The Journal of pharmacy and pharmacology,
B F Johnson, and H Greer, and J A McCrerie, and C Bye, and A S Fowle
June 1973, Lancet (London, England),
B F Johnson, and H Greer, and J A McCrerie, and C Bye, and A S Fowle
August 1974, Journal of pharmaceutical sciences,
B F Johnson, and H Greer, and J A McCrerie, and C Bye, and A S Fowle
November 1974, Acta pharmaceutica Suecica,
B F Johnson, and H Greer, and J A McCrerie, and C Bye, and A S Fowle
September 1974, JAMA,
B F Johnson, and H Greer, and J A McCrerie, and C Bye, and A S Fowle
January 1992, Yao xue xue bao = Acta pharmaceutica Sinica,
B F Johnson, and H Greer, and J A McCrerie, and C Bye, and A S Fowle
October 1977, Harefuah,
B F Johnson, and H Greer, and J A McCrerie, and C Bye, and A S Fowle
May 1974, The Medical journal of Australia,
B F Johnson, and H Greer, and J A McCrerie, and C Bye, and A S Fowle
January 1973, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!